Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new building at the University of Oxford's Botnar Institute for Musculoskeletal Sciences has been opened by The Duchess of Cornwall.

HRH The Duchess of Cornwall unveils a plaque © Keith Barnes Photography
HRH The Duchess of Cornwall unveils a plaque to mark the opening of the Marcela Botnar wing, with Professor Andrew Carr, Head of Department at NDORMS

The Botnar Institute for Musculoskeletal Sciences, on the site of the Nuffield Orthopaedic Centre in Headington, carries out research into improving the treatment of arthritis, osteoporosis and other bone and joint diseases. The new wing will focus on bio-engineering, with researchers working on developing new technologies, materials, and interventions to treat patients with musculoskeletal conditions.

The Duchess of Cornwall is Patron of the Nuffield Orthopaedic Centre (NOC) Charity, which raised £9M for the new wing.

Her Royal Highness toured the new facility, including a bio-manufacturing clean room which is the first university owned clean room in the UK. Here The Duchess was shown how synthetic biomaterials such as biopatches and bioyarns, for use in tissue repair, will be made in a sterile environment.

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) website. 

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.